Reuters - Treatment with the Alzheimer's
drug galantamine (Shire Pharmaceutical's Reminyl) reduces
repetitive verbalization by people with Alzheimer's disease,
according to a new study.
Source: http://rss.news.yahoo.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment